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a barrier, preventing the delivery of drugs or gene therapy to prevent restenosis. We hypothesize that microfabricated probes, manufactured using silicon fabrication technology, can penetrate through atherosclerotic plaque, creating paths for therapeutic delivery. Two sets of microfabricated probes (65 f 15 and 140 f 20 pm) were deployed in normal and atherosclerotic rabbit iliac artery segments (n=5 each) under distention pressures of 100, 200, 300, and 500 mmHg, to simulate deployed stents. The tissues were fixed while the probes remained in place and analyzed using standard SEM, TEM and light microscopy techniques to evaluate the extent and nature of vessel penetration. In healthy tissue, microprobes are able to pierce the internal elastic lamina and penetrate the media, with the highest probes nearly reaching the medidadventitia boundary. Atherosclerotic plaque is pierced by microprobes at all intraluminal pressures examined. These results indicate that microprobes may serve as a technique to penetrate the atherosclerotic plaque for the purpose of delivering therapeutics beyond the plaque.
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I. INTRODUCTION
Coronary atherosclerosis is the leading cause of death. Percutaneous Transluminal Coronary Angioplasty (FTCA), or "balloon angioplasty" is currently used to treat stenoses but is plagued by abnormal vascular wound healing and remodeling [l-31 which leads to restenosis. Although the initial success of balloon angioplasty is over 950/, one-third of patients return within six months due to restenosis, or the reoccurrence of the blockage. Intracoronary stenting has been shown to effectively reduce the incidence of restenosis (32% vs. 42%, p < 0.05) [4] . In addition, stents offer a platform for drug or gene therapy to treat the diseased artery. However, no stent design offers a solution on how to penetrate the -se atherosclerotic barrier so therapeutics can reach the portions of the vessel where wound healing and remodeling reside. The integration of various microfabrication technologies may provide a solution for a cost-effective local delivery system which incorporates the advantage of stenting while achieving therapeutic delivery beyond the atherosclerotic plaque.
Accordingly, we hypothesize that microprobes can produce controlled incisions into the arterial wall and pierce atherosclerotic plaque. In this way, microprobes integrated on the surface of an intracoronary stent may facilitate the delivery of drug or gene therapy through atherosclerotic plaque.
METHODS

A. Microprobe Fabrication
The microprobes are made from silicon, and are manufactured using silicon fabrication technology. Manufacturing processes include photolithography and anisotropic wet etching, where a 1.5 pm SiOz layer is grown at 1000 O C in wet oxygen on (100) oriented silicon wafers, forming a mask pattern [ 1 11. Mask formation is followed by two anisotropic etching steps which first create a truncated pyramid bounded by (411) planes followed by hrther undercutting etching to complete the pyramid under the oxide mask [ 121.
B. Simulating stent deployment
When applying the microprobes, post-stenting vessel distention was simulated. Clinically, stent deployment results in 10 to 30% vessel distention, corresponding to the maximum distensibility of the elastin fibers in the vessel wall [13] . This distention is reproduced in a harvested vessel which has relaxed both circumferentially and longitudinally by stretching the vessel 10 to 30% beyond its in vivo circumference (-1.4 times its relaxed circumference) [ 141. The intraluminal pressure seen by the lumen during stent deployment depends on the stiffness of the tissue, which increases with atherosclerotic plaque formation and the progression from a cellular to calcified lesion. The intraluminal pressure range (U) needed to distend healthy and diseased rabbit tissues was calculated from vessel wall compliance (C) and volume change (AV) measurements.
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The compliance of atherosclerotic rabbit vessels with 10 and 30% distention were 0.058.10-' mYmmHg and 0.061.10-3 " H g respectively [15] , corresponding to a pressure range of 150 to 500 " H g . Based on these figures the microprobes were applied at 100, 200, 300, and 500 " H g .
C. Animal Model of Atherosclerosis
The iliac arteries from (n=lO) New Zealand White rabbits were used to evaluate two available microprobe geometries: 1) 65 f 15 pm and 2) 140 f 20 pm microprobes. The atherosclerotic model was created by feeding (n=5) animals a hypercholesterolemic diet containing 5% cholesterol and 7% peanut oil for a period of three weeks. At the conclusion of the three week period, arterial injury was performed by balloon injury followed by an additional three weeks of the hgh cholesterol diet. This method has been shown to reproducibly create stenoses that resemble human atherosclerotic lesions.
D. Tissue Processing
Both iliac arteries were simultaneously dissected from the distal side of the inguinal ligament to the bottom of the aorta. The base of the aorta was ligated to allow cannulation of the iliac artery, permitting a brief pressure perfusion with a medium to rinse the vessel free of blood. The vessel was then dissected free of excess retroperitoneal tissue and opened longitudinally along its dorsal aspect. It was then clamped as a planar sheet at its in vivo length to prevent collapse or buckling of the segment according to the method of Fry et al. [16] . The vessels were sectioned and imaged using standard structural biology tissue processing and imaging techniques for scanning electron microscopy (SEM), transmitted electron microscopy (TEM), and light microscopy.
C. Experiment Apparatus and Tissue Imaging
The apparatus shown in Fig. 1 was designed to apply the microprobes to the tissue. Harvested vessel segments were mounted, endothelial side up, on the tissue holding device. The device is 10 to 30% wider than the mean in vivo vessel circumference [ 171. During microprobe application the chamber was purged with 2.5% gluteraldehyde for 20 minutes, preserving the interaction between the tissue and the microprobes. Following tissue fixation, the tissue damaged by the device pins adjacent to the chamber walls was trimmed from the specimen. Separate tissue processing protocols were then followed for imaging the tissue/microprobe interaction using SEM, TEM, or light microscopy. 
RESULTS
Microfabricated probes were found to produce uniform, controlled incisions into the arterial wall without damaging the endothelium adjacent to the microprobes (Fig. 2) . 65 It 15 pm microprobes failed to pierce the internal elastic lamina at all applied pressures while 140 f 20 pn microprobes pierced the internal elastic lamina at all applied pressures in normal rabbit iliac arteries (Fig. 3) . The microprobes were found to pierce through the internal elastic lamina (EL) and then cut into and compress the smooth muscle cells. The depth of penetration was proportional to the applied pressure. In no cases did the microprobes reach the external elastic lamina (EEL). The rabbit atherosclerotic lesions were composed of smooth muscle cells and foam cells on the luminal side of the plaque. They were cut and compressed at the tips of the microprobes when applied at the pressure range examined (150 to 500 " H g ) .
The microprobes were found to penetrate through the plaque. However, they could not penetrate through plaque thicker than the microprobe height (Fig. 4) . 
IV. DISCUSSION
Microfabricated probes, created using MEMS manufacturing techniques, can function as sharp piercing devices. Microprobes are able to pierce the arterial E L of normal vessels and penetrate into atherosclerotic plaque. The damage made by these incisions is controlled and does not affect the adjacent tissue, demonstrating the ability of this device to minimize damage.
The 65 f 15 pm microprobes were unable to pierce the E L of healthy vessels, while 140 f 20 pm microprobes were able to penetrate the same vessels at all intraluminal pressures examined. This result indicates that microprobe height is the parameter controlling whether or not the microprobe tips reach the media. Furthermore, 140 f 20 pm microprobes were not tall enough to reach the EEL, indicating that microprobes of certain height safely penetrate the media without transecting the entire vessel.
The rabbit model of atherosclerosis resulted in classic plaque formation, composed-of migrated medial smooth muscle cells, aggregate foam cells, and a disrupted E L [18] . 65 f 15 pm and 140 f 20 pm cut into plaque at all stent deployment intraluminal pressures. This result indicates that taller microprobes need to be developed for complete atherosclerotic plaque penetration.
V. CONCLUSIONS
The emerging field of microfabrication has given rise to devices with a variety of bioapplications. The ability of the microprobe to penetrate arterial walls and atherosclerotic plaque has been demonstrated. Microprobes of sufficient height are able to produce controlled incisions into muscular arteries and penetrate atherosclerotic plaque at all intraluminal post-stenting pressures. These results indicate that microprobes of sufficient height may reliably penetrate through the intima and facilitate the delivery of therapeutics through the atherosclerotic plaque. Hence, microprobes incorporated on the surface of an intravascular stent may possibly be used to deliver drug or gene therapy to the diseased vessel. Such a stent would underscore the potential for MEMS devices to treat human diseases.
